CS331491A3 - Cyclopeptides, process of their preparation and pharmaceuticals based thereon - Google Patents

Cyclopeptides, process of their preparation and pharmaceuticals based thereon

Info

Publication number
CS331491A3
CS331491A3 CS913314A CS331491A CS331491A3 CS 331491 A3 CS331491 A3 CS 331491A3 CS 913314 A CS913314 A CS 913314A CS 331491 A CS331491 A CS 331491A CS 331491 A3 CS331491 A3 CS 331491A3
Authority
CS
Czechoslovakia
Prior art keywords
cyclopeptides
preparation
pharmaceuticals based
pharmaceuticals
Prior art date
Application number
CS913314A
Other languages
Czech (cs)
English (en)
Inventor
Gunter Dr Holzemann
Alfred Dr Jonczyk
Jurgen Harting
Hartmut Greiner
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CS331491A3 publication Critical patent/CS331491A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CS913314A 1990-11-02 1991-11-01 Cyclopeptides, process of their preparation and pharmaceuticals based thereon CS331491A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4034829A DE4034829A1 (de) 1990-11-02 1990-11-02 Cyclopeptide

Publications (1)

Publication Number Publication Date
CS331491A3 true CS331491A3 (en) 1992-05-13

Family

ID=6417499

Family Applications (1)

Application Number Title Priority Date Filing Date
CS913314A CS331491A3 (en) 1990-11-02 1991-11-01 Cyclopeptides, process of their preparation and pharmaceuticals based thereon

Country Status (11)

Country Link
EP (1) EP0484719A3 (fr)
JP (1) JPH04300895A (fr)
KR (1) KR920009846A (fr)
AU (1) AU8676291A (fr)
CA (1) CA2054667A1 (fr)
CS (1) CS331491A3 (fr)
DE (1) DE4034829A1 (fr)
HU (1) HUT61582A (fr)
IE (1) IE913831A1 (fr)
PT (1) PT99384A (fr)
ZA (1) ZA918717B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231395T3 (de) 1991-09-20 2005-07-21 Glaxo Group Ltd., Greenford Neue medizinische Indikation für Tachykinin-Antagonisten
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
GB9620819D0 (en) * 1996-10-05 1996-11-20 Zeneca Ltd Chemical compounds
TR199802537T2 (xx) 1996-06-07 1999-03-22 Zeneca Limited Peptit t�revleri.
GB9621836D0 (en) 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
KR100408624B1 (ko) * 2000-10-06 2003-12-06 엘지전선 주식회사 전선용 ｐｖｃ 절연재료
EP2117538A1 (fr) 2007-01-24 2009-11-18 Glaxo Group Limited Compositions pharmaceutiques contenant du 2-méthoxy-5- (5-trifluorométhyl-tétrazol-i-yl-benzyl) - (2s-phényl-pipéridin-3s-yl-)
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
WO2013055984A1 (fr) 2011-10-14 2013-04-18 Bristol-Myers Squibb Company Composés tétrahydroisoquinolines substitués en tant qu'inhibiteurs du facteur xia
EP2766347B1 (fr) 2011-10-14 2016-05-04 Bristol-Myers Squibb Company Composés de tétrahydroisoquinoléine substitués en tant qu'inhibiteurs du facteur xia
JP6033319B2 (ja) 2011-10-14 2016-11-30 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 第ＸＩａ因子阻害剤としての置換テトラヒドロイソキノリン化合物
EP2906552B1 (fr) 2012-10-12 2017-11-22 Bristol-Myers Squibb Company Composés de tetrahydroisoquinoline substitués par guanidine en tant qu'inhibiteurs de factor xia
US9403774B2 (en) 2012-10-12 2016-08-02 Bristol-Myers Squibb Company Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors
TR201807316T4 (tr) 2012-10-12 2018-06-21 Bristol Myers Squibb Co Bir faktör XIa inhibitörünün kristalli formları.
WO2014160668A1 (fr) 2013-03-25 2014-10-02 Bristol-Myers Squibb Company Tétrahydroisoquinolines comprenant des azoles substitués en tant qu'inhibiteurs du facteur xia
SG10201908467RA (en) 2014-01-31 2019-10-30 Bristol Myers Squibb Co Macrocycles with hetrocyclic p2' groups as factor xia inhibitors
NO2760821T3 (fr) 2014-01-31 2018-03-10
ES2714283T3 (es) 2014-09-04 2019-05-28 Bristol Myers Squibb Co Macrociclos de diamida que son inhibidores de FXIa
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8807246D0 (en) * 1988-03-25 1988-04-27 Merck Sharp & Dohme Therapeutic agents
ZA906188B (en) * 1989-08-10 1991-06-26 Merrell Dow Pharma Cyclic neurokinin a antagonists

Also Published As

Publication number Publication date
AU8676291A (en) 1992-05-07
HUT61582A (en) 1993-01-28
DE4034829A1 (de) 1992-05-07
JPH04300895A (ja) 1992-10-23
KR920009846A (ko) 1992-06-25
EP0484719A2 (fr) 1992-05-13
HU913450D0 (en) 1992-01-28
IE913831A1 (en) 1992-05-22
EP0484719A3 (en) 1993-05-19
ZA918717B (en) 1992-08-26
CA2054667A1 (fr) 1992-05-03
PT99384A (pt) 1992-09-30

Similar Documents

Publication Publication Date Title
CS189391A3 (en) Dialkoxypiridylbenzimidazole derivatives, process of their preparation and their pharmaceutical use
CS331491A3 (en) Cyclopeptides, process of their preparation and pharmaceuticals based thereon
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
CS225991A3 (en) Substituted azoles, process of their preparation and their use
CS20091A2 (en) Basic calciumaluminiumhydroxidedicarboxylate, method of its preparation and its application
CS44091A3 (en) 1-phenylimidazole derivative, process of its preparation and use
AU8736691A (en) Cyclopeptides, a method of preparing them, and their use as drugs
ZA914296B (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
EP0257338A3 (en) Improved amphoteric starches and process for their preparation
CS202292A3 (en) Novel pyrrolopyrazines, process of their preparation and medicaments based thereon
CS299991A3 (en) Derivatives of 2-aminopyrimidine-4-carboxamide, process of their preparation and their application as medicaments
LTIP709A (en) Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations
HU913430D0 (en) 2-substituted-methyl-aryl-carboxylates, medical preparations containing them and process for their production
CS265391A3 (en) Novel thienodiazepines, process for their preparation and pharmaceutical comprising them
HU9802965D0 (en) Iminothiazolidine intermediers and process for their preparation
ZA919373B (en) Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and blends thereof
CS382891A3 (en) N-arylpiperizinealkaneamide derivatives, process of their preparation and pharmaceuticals based thereon
CS235091A3 (en) Novel derivatives of 1-diphenylmethylpiperazine, process of their preparation and their application as medicaments
ZA911927B (en) Labdanes and process for their preparation
IL100187A0 (en) Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and mixtures thereof
ZA906605B (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines,and process for their preparation
IL116968A0 (en) Ethyl 6-trichloroacetimidoxy-4-hexenoate and the process for the preparation thereof
EP0488009A3 (en) Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them
EP0459198A3 (en) Thioalkanones, procedure for their preparation and their use
CS97892A3 (en) Adenosine derivatives, process of their preparation and therapeuticalcompositions comprising said derivatives